Concurrent Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
Concurrent Pharmaceuticals, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include VITAE, CONTOUR, and VITAE PHARMACEUTICALS. The owner is based in West Conshocken, PA.
200 Barr Harbor Drive Suite 400
West Conshocken, PA 19428
Showing of trademarks Trademarks
Trademark Classifications
Concurrent Pharmaceuticals, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Concurrent Pharmaceuticals, Inc. have?
Concurrent Pharmaceuticals, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 3 registered, 5 abandoned, 3 cancelled.
What trademark classes does Concurrent Pharmaceuticals, Inc. file in?
Concurrent Pharmaceuticals, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Concurrent Pharmaceuticals, Inc.'s most well-known trademarks?
Concurrent Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as VITAE, CONTOUR, and VITAE PHARMACEUTICALS. These are among 3 currently registered trademarks in the portfolio.
What is Concurrent Pharmaceuticals, Inc.'s trademark registration success rate?
Concurrent Pharmaceuticals, Inc. has a 27% trademark registration rate, with 3 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.